CMS just announced new glycemic management quality metrics that hospitals will need to start collecting and reporting publicly. CMS is making it clear that severe hypoglycemia related to insulin should be a never event and that hospitals should work towards that goal alongside prioritizing the optimal treatment and management of severe hyperglycemia.
Dr. Jordan Messler, Chief Medical Officer at Glytec, will share how this measure impacts hospitals’ people, process and bottom lines, the timelines for roll out and how hospital leaders can prepare for this landmark glycemic management measure.
Register and bring your questions!
Following the CMS overview, we’ll share how Glytec’s eGlycemic Management System® (eGMS) is revolutionizing glycemic management by uniting teams around patient safety.
Glytec’s eGMS is an EHR-integrated, cloud-based software solution that supports safe and effective glycemic management and insulin dosing.
eGMS offers personalized insulin dosing decision support at the point of care. Unlike paper protocols, sliding scale methods and digital insulin calculators, eGMS uses an evidence-based, FDA-cleared algorithm, Glucommander™. Glucommander leverages real-time and historical data to personalize insulin dosing by learning each patient’s insulin sensitivity and anticipating future need.
The result? Patients experiencing glycemic management challenges get into target range faster, stay within tighter parameters and experience fewer insulin-related adverse drug events than patients treated with other protocols.
In addition to dosing support, eGMS offers tools for providers, nurses, pharmacists, CDCESs, hospital leadership and others to optimize insulin management.
Join us to see how Glytec’s eGMS can ensure best practice for your insulin-requiring patients.
You Might Also Like